Investing Acceleration of RAD204 Phase 1 dose escalation trial May 12, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com 0 Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Excellent Gold Intersections Verified at Kiimala Project May 12, 2025 Related Posts American Uranium December 16, 2025 Crypto Market Update: UK Moves To Place Crypto Firms Under FCA Regulation December 16, 2025 Angkor Resources Signs Letter of Intent to Sell Evesham Oil Production December 16, 2025
